Loading data
CEVANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 14.16 m USD | 12.77 m USD | 11.65 m USD | 15.13 m USD | 10.38 m USD |
| Gross profit | 95.44 m USD | 94.17 m USD | 85.77 m USD | 105.45 m USD | 103.45 m USD |
| Research and development expense | 74.83 m USD | 71.62 m USD | 72.69 m USD | 70.32 m USD | 69.09 m USD |
| Operating profit | -11.35 m USD | -7.55 m USD | -13.47 m USD | 3.9 m USD | 7.04 m USD |
| Profit before tax | -4.69 m USD | -2.76 m USD | -8.21 m USD | 4.2 m USD | 9.22 m USD |
| Income tax expense | 5.95 m USD | 6.03 m USD | 10.23 m USD | 18.08 m USD | 6.82 m USD |
| Net income (reported basis) | -10.64 m USD | -8.79 m USD | -11.88 m USD | -23.18 m USD | 396 k USD |
| Basic earnings per share | -0.44 USD/share | -0.37 USD/share | -0.51 USD/share | -1 USD/share | 0.02 USD/share |
| Diluted earnings per share | -0.44 USD/share | -0.37 USD/share | -0.51 USD/share | -1 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.